KZIA
Kazia Therapeutics Ltd
8.90$
+1.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +1.5% | -9.1% | -5.3% | -14.2% | -29.7% | -63.8% | -20.2% | -29.8% | -58.1% | -69.9% | +1,244.7% | +70.2% | +0.5% | +11.8% | +119.9% | +9.4% | -29.9% | +0.0% | +16.7% | +47.7% | +0.0% | +0.0% | -50.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -39.3% | -10.6% | -11.8% | -30.0% | – | – | – | +39.0% | -68.1% | +49.1% | +6.5% | +143.1% | +163.0% | -30.8% | -54.0% | +22.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -118.8% | – | +1,024.5% | -425.8% | – | -57.3% | +302.3% | -99.0% | -2,484.9% | – | – | |
| – | – | +55.8% | +25.1% | -48.1% | -105.0% | – | – | +315.8% | -12.5% | -61.9% | -236.1% | – | +351.1% | -341.2% | – | +131.6% | -165.2% | – | – | -77.0% | +372.8% | -435.0% | – | +402.6% | +130.9% | -130.1% | |
| – | -45.5% | -30.5% | +0.0% | -59.7% | -6.1% | +6.3% | -57.6% | -6.2% | -68.2% | -1.2% | -76.6% | +154.5% | -98.2% | +915.1% | +165.7% | +261.3% | +438.6% | -97.8% | -100.0% | – | – | – | – | – | – | – | |
| – | -47.8% | – | – | +588.3% | – | – | -58.9% | -87.8% | – | -102.4% | -88.8% | – | -97.9% | +2,758.6% | -115.7% | +232.4% | +482.1% | +1,263.5% | – | +1,472.7% | -200.2% | +0.0% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | 0.0% | -98.3% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | -51.0% | +101.3% | -60.0% | -99.2% | +28,593.0% | -83.5% | -99.9% | +615,695.8% | -31.9% | -31.8% | – | – | +129.0% | +72.5% | +82.6% | +762.1% | -98.4% | -102.3% | – | +0.0% | +218.1% | +131.5% | -86.7% | +248.1% | -53.9% | +167.0% | |
| – | -107.8% | – | +94.8% | -200.7% | – | -141.4% | – | – | -151.5% | – | – | – | – | -340.5% | – | – | -126.1% | – | – | – | – | +465.3% | -207.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.